Who is TYSABRI for?
TYSABRI is a prescription medicine approved for adult patients with relapsing forms of MS to slow the worsening of disability that is common in patients with MS and decrease the number of flare-ups (relapses). Because TYSABRI increases the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection that usually causes death or severe disability, TYSABRI is generally recommended for patients that have not been helped enough by, or cannot tolerate, another treatment for MS. TYSABRI does not cure MS and has not been studied for longer than two years or in patients with chronic progressive MS.
Related Questions
- Could you please explain the withdrawal of the drug Tysabri from the market and the impact this will have on the treatment of veterans with MS?
- Have there been any cases of PML in the 5000 patients receiving Tysabri through their primary physician?
- What is the most important information I should know about Tysabri (Natalizumab)?
